Related Experiment Video
Updated: May 16, 2026
05:26
Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
High dose statins in acute myocardial infarction
Thomas George1, Mullasari S Ajit
1Institute of Cardiovascular Diseases, Madras Medical Mission, Chennai,Tamil Nadu, India.
Indian Heart Journal
|November 30, 2012
Summary
Early high-dose statin therapy helps stabilize vulnerable plaques in patients with acute myocardial infarction. This intervention reduces the risk of death and recurrent coronary events, improving secondary prevention outcomes.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Patients with acute myocardial infarction face high risks of mortality and recurrent events due to unstable coronary plaques.
- Vulnerable plaque stabilization is a critical therapeutic strategy for these high-risk individuals.
Purpose of the Study:
- To evaluate the benefits of early high-dose statin initiation in stabilizing vulnerable plaques.
- To assess the impact of statins on reducing coronary events and death in acute myocardial infarction patients.
Main Methods:
- Review of secondary prevention trials examining high-dose statin therapy.
- Analysis of the pleiotropic effects of statins on coronary plaque stability.
Main Results:
- High-dose statins demonstrated utility and safety in secondary prevention.
- Early statin initiation showed benefits in stabilizing vulnerable plaques.
Conclusions:
- Early high-dose statin therapy is beneficial for acute myocardial infarction patients.
- Statins reduce coronary events and mortality by stabilizing vulnerable plaques through pleiotropic effects.
More Related Videos
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...